NCT00568542View on ClinicalTrials.gov

Chronic, Low Dose Erythropoetin Beta in Ischemic Cardiomyopathy

PHASE4CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Ischemic Cardiomyopathy
Interventions
DRUG

erythropoetin beta

35 I.E. kg body weight subcutaneous once per week for 6 months

DRUG

placebo

35 I.E. kg body weight placebo to erythropoetin beta

Trial Locations (2)

13125

Charité Campus Buch, Berlin

13353

Charité Campus Virchow, Berlin

All Listed Sponsors
lead

Charite University, Berlin, Germany

OTHER

NCT00568542 - Chronic, Low Dose Erythropoetin Beta in Ischemic Cardiomyopathy | Biotech Hunter | Biotech Hunter